New

Schizophrenia Risk Alleles, Peer Victimization Associated With Emotional Problems in Youth

Peer victimization may be an important modifiable factor in improving the developmental course among children.

New

Sudden Symptomatic Improvement Predicts Response to Antidepressant Therapy

Recent evidence suggests that early sudden improvements have lasting effects and occur in most patients receiving antidepressants.

New

Subthreshold Pediatric Bipolar Disorder Is a Significant Psychiatric Burden

Researchers evaluated the relationship between pediatric subthreshold bipolar disorder and significant psychiatric impairments and increased rates of suicidality.

New

Aspirin, N-Acetylcysteine Effective Adjunctive Treatments in Bipolar Depression

Investigators examine the therapeutic effects of NSAIDs and NAC in patients with bipolar disorder.

New

Dental Procedure-Related Opioid Exposure and Later Risk for Opioid Abuse

A substantial proportion of adolescent and young adults receiving opioids for dental procedures may be at higher risk for later opioid use and abuse.

New

Higher Neuroticism Linked to Anxiety, Anhedonia in Depression

Researchers sought to determine whether neuroticism significantly contributes to higher anxiety and anhedonia and further studied whether cognitive control leads to lower anxiety.

New

Interview-Only Version of Yale-Brown Obsessive-Compulsive Scale Effective for OCD Monitoring in Youth

Study data found that a single 60-minute interview session may be sufficient for capturing obsessive-compulsive symptoms in youth.

New

Blood-Based Medication Monitoring May Effectively ID Patient Medication Use

Comprehensive medication monitoring “has merit” in identifying patient compliance.

New

Characteristics of Unipolar Mania, Distinct from Bipolar Disorder, Described

Investigators sought to compare differences in clinical characteristics between patients with mania and those with bipolar disorder I.

New

Potential Biomarker Differentiates Between Bipolar Disorder With, Without Psychosis

Altered glucose uptake in certain key regions in the brain may serve as a potential biomarker for key features in bipolar disorder.

New

When Treating Depression With ECT, 2 Lobes Are Better Than 1

Investigators observed whole-brain gray matter volumetric changes after treating patients with treatment-resistant depression with bi-temporal stimulation or right unilateral electroconvulsive therapy.

New

Challenging Stigma: Should Psychiatrists Disclose Their Own Mental Illness?

Psychologists and psychiatrists discuss the stigma of mental health disorders in practicing clinicians.

New

Interaction Observed Between Age, Treatment Outcomes for Long-Acting Injectable Antipsychotic Medications

Researchers investigated subgroup responses to long-acting injectable medications haloperidol decanoate and paliperidone palmitate.

New

Physical Frailty Associated With Symptoms of Dementia, Caregiver Burden in Alzheimer Disease

Per study data published in the Journal of Clinical Psychiatry, investigators hypothesized that the correlation between higher Frailty Index scores and increased caregiver burden was partially mediated by increased behavioral and psychological symptoms of dementia.

New

Social Anxiety in Schizophrenia: An Overlooked Problem

Emerging evidence has begun to elucidate the prevalence and outcomes associated with social anxiety disorder in schizophrenia.

New

Social Media and the Spread of Misinformation: Taking Back Public Health

Public health misinformation is often amplified within information silos and echo chambers.

New

No Significant Differences in Epidermal Growth Factor, Fibroblast Growth Factor-2 in Elderly With MDD

Findings indicated that no significance of epidermal growth factor levels and fibroblast growth factor-2 levels were found in elderly patients with major depressive disorder.